pfizer has one-upped the competition with a $14 billion bid for a cancer drugmaker
Published 7 years ago • 55 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
39:22
developing the covid-19 vaccines with 2023 nierenberg prize winner katalin karikó
-
5:37
what's the deal with pfizer's covid-19 vaccine? | scishow news
-
5:43
public citizen blasts pfizer for putting corporate profit over increasing access to covid vaccines
-
3:34
study: pfizer vaccine effective for people with chronic diseases | anc
-
6:42
pfizer wont' give away its secret vaccine recipe
-
17:57
how biontech used cancer research to create its covid vaccine
-
11:46
how covid vaccine tech could fight cancer soon
-
27:01
lifespan to announce results of vaccine trial for aggressive brain cancer
-
28:23
moderna vaccine had decade head start over pfizer: chairman
-
22:51
covid-19: is the pfizer-biontech vaccine safe? | in conversation | chief strategy officer, biontech
-
5:28
fauci: pfizer's covid-19 vaccine trial success may boost acceptance
-
8:24
top pfizer scientist discusses covid-19 vaccine's efficacy and new variants
-
23:16
the race for a covid-19 vaccine with moderna, pfizer and biontech | wired health:tech 2020
-
9:36
inside the race for a covid-19 vaccine: part 1
-
12:03
coronavirus vaccine race: a matter of political prestige | covid-19 special
-
6:27
pfizer testing its vaccine on children under age 12
-
21:48
“a vaccine for the world”: u.s. scientists develop low-cost shot to inoculate global south
-
12:00
doctor: pfizer's covid-19 vaccine "extremely safe" to take
-
44:23
stakeholder call: pfizer-biontech covid-19 vaccine booster dose - 9/24/21
-
6:01
news wrap: fda to grant full approval to pfizer's covid vaccine next week
-
4:17
doctor in pfizer trial talks distribution of covid vaccine
-
4:50
new study: delaying 2nd pfizer covid vaccine dose can result in stronger antibody response